Researchers have zeroed in on yet another possible ocular concern for diabetes patients who take popular GLP-1 therapies in a ...

Days after FDA Commissioner Marty Makary said that the agency planned to review the safety of abortion pill mifepristone, ...

The PD-(L)1xVEGF field had a roller coaster week marked by an imperfect readout and a potentially $11 billion deal. | The PD- ...

Drugmakers and contract manufacturers are responding to the booming demand for antibody-drug conjugates, with multiple ...

After a long winter, the start of summer is ushering in some much-needed sunshine, warmer weather and, for a handful of ...

Orca Bio is preparing to make a splash in the cell therapy market. | Orca Bio is preparing to make a splash in the cell ...

The Council is now set to begin negotiations with the European Parliament on the package, after which the rules would be ...

Amneal Pharmaceuticals is recalling three lots of sulfamethoxazole/trimethoprim tablets because of microbial contamination ...

A little less than a year after cutting the ribbon at a new glass syringe factory in Hungary, Schott Pharma is making good on ...

Bayer has taken another step toward achieving its €3 billion peak sales estimate for androgen receptor inhibitor Nubeqa, ...

With the American Society of Clinical Oncology (ASCO) annual meeting in full swing at Chicago’s McCormick Place this past ...

Almost exactly a year after launching its Obesity Association, the American Diabetes Association (ADA) has recruited Novo ...